What does CardioZen do?

CardioZen is a specialist medical practice in Grez-Doiceau. Private Limited, started on 18 January 2019, 1 establishment.

What is the address of CardioZen?

The registered office of CardioZen is located at Rue du Grand Sart 10, 1390 Grez-Doiceau.

Is CardioZen still active?

Yes. According to the CBE (30 October 2026) CardioZen is active, legal situation “Normale toestand”, started on 18 January 2019.

Is CardioZen registered on Peppol?

Yes, CardioZen is registered on the Peppol network with ID 0208:0718894120.

What is the enterprise number of CardioZen?

The enterprise number of CardioZen is BE0718894120.

When was CardioZen founded?

CardioZen was founded on 18 January 2019.

Who are the directors of CardioZen?

According to the 2025 annual accounts, the directors of CardioZen are: Marc Vincent.

Is CardioZen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 January 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CardioZen make in 2025?

CardioZen posted a profit after taxes of € 114,150 in financial year 2025.

What is the revenue of CardioZen?

As a small company, CardioZen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 230,594.

CardioZen (Private Limited) - Grez-Doiceau - BE0718894120

Dossier CardioZen, printed on 30 October 2026 from databakkes.be/en/0718894120/cardiozen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CardioZen from Grez-Doiceau, company number BE0718894120, closed financial year 2025 with a result of € 114,150 after tax. For that financial year CardioZen recorded a gross margin of € 230,594 and equity of € 95,536. Compared with financial year 2024, the result moved from € 108,056 to € 114,150. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 19, 2026.

What it is worth Healthy

€ 95,536

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 114,150

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 87,700

▲ € 78,506 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 114,150 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 10,562

▲ 185% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 27,455

▼ 5% vs 2024

€ 4,799 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 10,342

▼ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 18,381

▲ 1% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 106,131 Gross margin 2022: € 106,131 First fiscal year in the series	€ 156,419 Gross margin 2023: € 156,419 ▲ 47% vs 2022 (€ 106,131) Favourable step	€ 260,713 Gross margin 2024: € 260,713 ▲ 67% vs 2023 (€ 156,419) Favourable step	€ 230,594 Gross margin 2025: € 230,594 ▼ 12% vs 2024 (€ 260,713) Unfavourable step	▼ 12%
Profit after taxes	€ 46,947 Profit after taxes 2022: € 46,947 First fiscal year in the series	€ 76,936 Profit after taxes 2023: € 76,936 ▲ 64% vs 2022 (€ 46,947) Favourable step	€ 108,056 Profit after taxes 2024: € 108,056 ▲ 40% vs 2023 (€ 76,936) Favourable step	€ 114,150 Profit after taxes 2025: € 114,150 ▲ 6% vs 2024 (€ 108,056) Favourable step	▲ 6%
Equity	€ 158,006 Equity 2022: € 158,006 First fiscal year in the series	€ 95,536 Equity 2023: € 95,536 ▼ 40% vs 2022 (€ 158,006) Unfavourable step	€ 95,536 Equity 2024: € 95,536 Unchanged (€ 95,536) Unchanged	€ 95,536 Equity 2025: € 95,536 Unchanged (€ 95,536) Unchanged
Total debts	€ 187,764 Total debts 2022: € 187,764 First fiscal year in the series	€ 280,333 Total debts 2023: € 280,333 ▲ 49% vs 2022 (€ 187,764) Unfavourable step	€ 153,272 Total debts 2024: € 153,272 ▼ 45% vs 2023 (€ 280,333) Favourable step	€ 204,362 Total debts 2025: € 204,362 ▲ 33% vs 2024 (€ 153,272) Unfavourable step	▲ 33%
Cash	€ 28,427 Cash 2022: € 28,427 First fiscal year in the series	€ 29,930 Cash 2023: € 29,930 ▲ 5% vs 2022 (€ 28,427) Favourable step	€ 9,194 Cash 2024: € 9,194 ▼ 69% vs 2023 (€ 29,930) Unfavourable step	€ 87,700 Cash 2025: € 87,700 ▲ € 78,506 vs 2024 (€ 9,194) Favourable step	▲ € 78,506
Retained profit	€ 139,406 Retained profit 2022: € 139,406 First fiscal year in the series	€ 76,936 Retained profit 2023: € 76,936 ▼ 45% vs 2022 (€ 139,406) Unfavourable step	€ 76,936 Retained profit 2024: € 76,936 Unchanged (€ 76,936) Unchanged	€ 76,936 Retained profit 2025: € 76,936 Unchanged (€ 76,936) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 139,406 Dividend 2023: € 139,406 Unchanged (€ 0) Unchanged	€ 108,056 Dividend 2024: € 108,056 ▼ 22% vs 2023 (€ 139,406) Unchanged	€ 114,150 Dividend 2025: € 114,150 ▲ 6% vs 2024 (€ 108,056) Unchanged	▲ 6%
Bank debt	€ 153,870 Bank debt 2022: € 153,870 First fiscal year in the series	€ 107,550 Bank debt 2023: € 107,550 ▼ 30% vs 2022 (€ 153,870) Favourable step	€ 29,013 Bank debt 2024: € 29,013 ▼ 73% vs 2023 (€ 107,550) Favourable step	€ 27,455 Bank debt 2025: € 27,455 ▼ 5% vs 2024 (€ 29,013) Favourable step	▼ 5%
Balance sheet total	€ 345,770 Balance sheet total 2022: € 345,770 First fiscal year in the series	€ 375,869 Balance sheet total 2023: € 375,869 ▲ 9% vs 2022 (€ 345,770) Unchanged	€ 277,654 Balance sheet total 2024: € 277,654 ▼ 26% vs 2023 (€ 375,869) Unchanged	€ 329,632 Balance sheet total 2025: € 329,632 ▲ 19% vs 2024 (€ 277,654) Unchanged	▲ 19%

Key figures of CardioZen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CardioZen?

What happened at CardioZen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 19, 2026 New annual accounts for financial year 2025: profit of € 114,150 (▲ 6% vs 2024). Source: NBB ↗
Feb 1, 2019 New establishment in Grez-Doiceau. KBO
Jan 18, 2019 Start of the company according to the CBE. KBO

In short

From € 46,947 profit in 2022 to € 114,150 profit in 2025.

Paid € 129,913 in corporate taxes since 2022.

Best year ever: 2025, with € 114,150 profit.

Paid out € 361,612 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Marc Vincent

CardioZen

IMMOBILIERE CENTRE MEDICAL DU SOLBOSCH

immobiliere du solboch

Behind CardioZen is Marc Vincent. Marc Vincent is also behind IMMOBILIERE CENTRE MEDICAL DU SOLBOSCH and immobiliere du solboch.

Directors

According to the 2025 annual accounts

Marc Vincent

Director

Also active at: IMMOBILIERE CENTRE MEDICAL DU SOLBOSCH, immobiliere du solboch

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Grand Sart 10

1390 Grez-Doiceau

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DocZen

€ 189,018 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0718.894.120
VAT number: BE 0718.894.120
Registered office: Rue du Grand Sart 10, 1390 Grez-Doiceau
Names & denominations: CardioZen
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 January 2019
Peppol: Active · Active since 8 Dec 2025
Contact: +320000000
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗